Downregulating KIT with a siRNA or HSP90AA1 inhibitors effectively reduced phosphorylated KIT and downstream signaling, which induced cell death and tumor shrinkage in IM-resistant GIST48 and GIST430 cells [12, 13, 26]. This evidence concerns the gene KIT and neoplasm.